XenoPort to Present at the Cowen and Company 33rd Annual Health Care … – MarketWatch (press release)

by admin on March 2, 2013


MarketWatch (press release)
XenoPort to Present at the Cowen and Company 33rd Annual Health Care
MarketWatch (press release)
Horizant(R) (gabapentin enacarbil) Extended-Release Tablets is approved in the United States for the treatment of moderate-to-severe primary restless legs syndrome (RLS) in adults and for the management of postherpetic neuralgia in adults.

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: